Elanco Animal Health (ELAN) Total Debt Growth (3y) (2021 - 2026)
Elanco Animal Health (ELAN) Total Debt Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | -2.21% |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | -7.03% |
| 3 | Zoetis | 32.69 Bn | 30.75 Bn | 1.62 Bn | 11.29% |
| 4 | Takeda Pharmaceutical | 27.61 Bn | 23.55 Bn | 4.39 Bn | 63.29% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | -7.76% |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.53 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -14.15% |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | 50.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.15% |
| Dec 31, 2025 | -13.05% |
| Sep 30, 2025 | -13.86% |
| Jun 30, 2025 | -11.46% |
| Mar 31, 2025 | -10.81% |
| Dec 31, 2024 | -13.22% |
| Sep 30, 2024 | -11.71% |
| Jun 30, 2024 | -11.99% |
| Mar 31, 2024 | -5.20% |
| Dec 31, 2023 | -4.54% |
| Sep 30, 2023 | 1.82% |
| Jun 30, 2023 | 43.14% |
| Mar 31, 2023 | 42.34% |
| Dec 31, 2022 | 35.32% |
| Sep 30, 2022 | 323.46% |
| Jun 30, 2022 | 313.27% |
| Mar 31, 2022 | 35.95% |
| Dec 31, 2021 | 38.28% |
| Sep 30, 2021 | 115.96% |